<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">anatomy</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал анатомии и гистопатологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Anatomy and Histopathology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-7357</issn><publisher><publisher-name>N.N. Burdenko Voronezh State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18499/2225-7357-2019-8-1-49-54</article-id><article-id custom-type="elpub" pub-id-type="custom">anatomy-816</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Фармакологическая коррекция экспериментального острого токсического гепатита</article-title><trans-title-group xml:lang="en"><trans-title>Pharmacological Correction of Experimental Acute Toxic Hepatitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мязин</surname><given-names>Р. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Myazin</surname><given-names>R. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мязин Роман ГеннадиевичКафедра пропедевтики внутренних болезней, </p><p>пл. Павших борцов, 1, г. Волгоград, 400131</p></bio><bio xml:lang="en"><p>Roman Myazin</p><p>pl. Pavshikh bortsov, 1, Volgograd, 400131 </p></bio><email xlink:type="simple">naclo@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Снигур</surname><given-names>Г. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Snigur</surname><given-names>G. L.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Емельянов</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Emel'yanov</surname><given-names>D. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернышова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyshova</surname><given-names>M. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава России, г. Волгоград</institution></aff><aff xml:lang="en"><institution>Volgograd State Medical University, Volgograd</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>05</day><month>04</month><year>2019</year></pub-date><volume>8</volume><issue>1</issue><fpage>49</fpage><lpage>54</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мязин Р.Г., Снигур Г.Л., Емельянов Д.Н., Чернышова М.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Мязин Р.Г., Снигур Г.Л., Емельянов Д.Н., Чернышова М.В.</copyright-holder><copyright-holder xml:lang="en">Myazin R.G., Snigur G.L., Emel'yanov D.N., Chernyshova M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://anatomy.elpub.ru/jour/article/view/816">https://anatomy.elpub.ru/jour/article/view/816</self-uri><abstract><p>Цель работы – разработка новых методов лечения острых токсических гепатитов. Изучена динамика патологических изменений в ткани печени при острой интоксикации после фармакологической коррекции гипохлоритом натрия.</p><sec><title>Материал и методы</title><p>Материал и методы. Работа выполнена на 45 крысах-самцах, у которых экспериментально воспроизведена модель острого токсического гепатоза. 1-ю группу составляли интактные особи, 2-й группе животных интрагастрально вводили аллиловый спирт с формированием у них острого токсического гепатоза, у 3-й группы крыс острый токсический гепатоз, вызванный введением аллилового спирта, корректировали гипохлоритом натрия, у 4-й группы медикаментозную коррекцию острого токсического гепатоза проводили с помощью эссенциале Н, животным 5-й группы фармакологическую коррекцию гепатоза проводили сочетанным применением гипохлорита натрия и эссенциале Н. На 6-е сут животных выводили из эксперимента с последующим гистологическим исследованием ткани печени.</p></sec><sec><title>Результаты</title><p>Результаты. Введение аллилового спирта сопровождалось выраженными изменениями гепатоцитов в виде дистрофических, некротических процессов и нарушения кровообращения в печеночных дольках. Фармакологическая коррекция гипохлоритом натрия, эссенциале Н или их комбинацией не способствовала полному гистологическому восстановлению гепатоцитов печени, однако под влиянием гипохлорита натрия или его комбинации с эссенциале Н степень выраженности жировой дистрофии существенно уменьшалась.</p></sec><sec><title>Выводы</title><p>Выводы. Применение гипохлорита натрия в качестве монотерапии или в комбинации его с эссенциале Н при острым токсическим гепатите способствует снижению степени тяжести жировой дистрофии печени. 0.03% раствор гипохлорита натрия может быть эффективен как в качестве самостоятельного метода лечения острого токсического гепатита, так и в комбинации с другими гепатопротекторами.</p></sec></abstract><trans-abstract xml:lang="en"><p>The aim of study was to develop new methods of treatment of acute toxic hepatitis. To achieve this objective, the authors investigated dynamics of pathological changes in the hepatic tissue under acute intoxication followed by the pharmacological correction with sodium hypochlorite.</p><sec><title>Material and methods</title><p>Material and methods. The study included 45 male rats that were subjected to the experimental simulation of acute toxic hepatosis. Group 1 included intact animals; group 2 included animals that were intragastrically administered allyl alcohol resulting in acute toxic hepatosis; group 3 included rats with acute toxic hepatosis caused by allyl alcohol introduction that was corrected by sodium hypochlorite; group 4 included animals with acute toxic hepatosis corrected by essentiale N; group 5 included animals with acute toxic hepatosis corrected by the combined application of sodium hypochlorite and essentiale N. On the 6th day the animals were removed from the experiment with the followed histological examination of the hepatic tissue.</p></sec><sec><title>Results</title><p>Results. The introduction of allyl alcohol was accompanied by significant changes in hepatocytes expressed by dystrophic, necrotic processes and circulatory disorders of the hepatic lobules. Pharmacological correction by sodium hypochlorite, essential H, or their combination did not result in the complete histological recovery of hepatocytes; however, the degree of fatty degeneration decreased significantly under the influence of sodium hypochlorite or its combination with essentiale N.</p></sec><sec><title>Conclusions</title><p>Conclusions. The application of sodium hypochlorite as a monotherapy or in combination with essential N in acute toxic hepatitis has allowed to relieve the severity of fatty liver disease. 0.03% solution of sodium hypochlorite can be effective as both - an independent method for treating acute toxic hepatitis, and in combination with other hepatoprotectors.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>острый токсический гепатит</kwd><kwd>аллиловый спирт</kwd><kwd>гипохлорит натрия</kwd><kwd>эссенциале Н</kwd><kwd>гепатоциты</kwd><kwd>химическое и лекарственное повреждение печени</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute toxic hepatitis</kwd><kwd>allyl alcohol</kwd><kwd>sodium hypochlorite</kwd><kwd>essentiale N</kwd><kwd>hepatocytes</kwd><kwd>chemical and drug induced liver injury.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Венгеровский А. И., Маркова И. В. Доклиническое изучение гепатозащитных средств. Ведомости Фармакологического Комитета. 1999; 2: 9–12 [Vengerovskii AI, Markova IV. Doklinicheskoe izuchenie gepatozashchitnykh sredstv. Vedomosti Farmakologicheskogo Komiteta. 1999;(2):9–12] (in Russian).</mixed-citation><mixed-citation xml:lang="en">Венгеровский А. И., Маркова И. В. Доклиническое изучение гепатозащитных средств. Ведомости Фармакологического Комитета. 1999; 2: 9–12 [Vengerovskii AI, Markova IV. Doklinicheskoe izuchenie gepatozashchitnykh sredstv. Vedomosti Farmakologicheskogo Komiteta. 1999;(2):9–12] (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Голиков С. Н., Саноцкий И. В., Тиунов Л. А. Общие механизмы токсического действия. М.; 1986. 280 [Golikov SN, Sanotskii IV, Tiunov LA. Obshchie mekhanizmy toksicheskogo deistviya. Moscow; 1986] (in Russian).</mixed-citation><mixed-citation xml:lang="en">Голиков С. Н., Саноцкий И. В., Тиунов Л. А. Общие механизмы токсического действия. М.; 1986. 280 [Golikov SN, Sanotskii IV, Tiunov LA. Obshchie mekhanizmy toksicheskogo deistviya. Moscow; 1986] (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Емельянов Д. Н., Мязин Р. Г. Оценка влияния терапии гипохлоритом натрия на перекисное окисление липидов, антиоксидантную защиту, синдромы цитолиза и холестаза у больных токсическими гепатитами. Вестник АГИУВ. 2013;</mixed-citation><mixed-citation xml:lang="en">Емельянов Д. Н., Мязин Р. Г. Оценка влияния терапии гипохлоритом натрия на перекисное окисление липидов, антиоксидантную защиту, синдромы цитолиза и холестаза у больных токсическими гепатитами. Вестник АГИУВ. 2013;</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">: 79–81 [Yemelyanov DN, Myazin RG. Assessment of influence of therapy by sodium hypochlorite on perekisny oxidation of lipids, antioxidatic protection, syndromes of cytolysis and a cholestasia at patients with toxic hepatitises. Herald of Almaty State Institute of Advanced Medical Education. 2013;(4):79–81] (in Russian).</mixed-citation><mixed-citation xml:lang="en">: 79–81 [Yemelyanov DN, Myazin RG. Assessment of influence of therapy by sodium hypochlorite on perekisny oxidation of lipids, antioxidatic protection, syndromes of cytolysis and a cholestasia at patients with toxic hepatitises. Herald of Almaty State Institute of Advanced Medical Education. 2013;(4):79–81] (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В. Т. Болезни печени и желчевыводящих путей: Руководство для врачей. М.; 2005. 536 [Ivashkin VT. Bolezni pecheni i zhelchevyvodyashchikh putei: Rukovodstvo dlya vrachei. Moscow; 2005] (in Russian).</mixed-citation><mixed-citation xml:lang="en">Ивашкин В. Т. Болезни печени и желчевыводящих путей: Руководство для врачей. М.; 2005. 536 [Ivashkin VT. Bolezni pecheni i zhelchevyvodyashchikh putei: Rukovodstvo dlya vrachei. Moscow; 2005] (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Коржевский Д. Э., Гиляров А. В. Основы гистологической техники. СПб.: СпецЛит; 2010. 95 [Korzhevskii DE, Gilyarov AV. Osnovy gistologicheskoi tekhniki. Saint Petersburg: SpetsLit; 2010] (in Russian).</mixed-citation><mixed-citation xml:lang="en">Коржевский Д. Э., Гиляров А. В. Основы гистологической техники. СПб.: СпецЛит; 2010. 95 [Korzhevskii DE, Gilyarov AV. Osnovy gistologicheskoi tekhniki. Saint Petersburg: SpetsLit; 2010] (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Лопаткин Н. А., Лопухин Ю. М. Эфферентные методы в медицине. М.; 1989. 352 [Lopatkin NA, Lopukhin YuM. Efferentnye metody v meditsine. Moscow; 1989].</mixed-citation><mixed-citation xml:lang="en">Лопаткин Н. А., Лопухин Ю. М. Эфферентные методы в медицине. М.; 1989. 352 [Lopatkin NA, Lopukhin YuM. Efferentnye metody v meditsine. Moscow; 1989].</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мязин Р. Г. Патент РФ № 2275921; 2006 [Myazin RG. Patent RF № 2275921; 2006]. URL: https://patents.google.com/patent/RU2275921C2/ru (дата обращения: 31.08.2018)</mixed-citation><mixed-citation xml:lang="en">Мязин Р. Г. Патент РФ № 2275921; 2006 [Myazin RG. Patent RF № 2275921; 2006]. URL: https://patents.google.com/patent/RU2275921C2/ru (дата обращения: 31.08.2018)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Подымова С. Д. Болезни печени: Руководство для врачей. М.; 2018. 984 [Podymova SD. Bolezni pecheni: Rukovodstvo dlya vrachei. Moscow: Medical information Agency; 2018].</mixed-citation><mixed-citation xml:lang="en">Подымова С. Д. Болезни печени: Руководство для врачей. М.; 2018. 984 [Podymova SD. Bolezni pecheni: Rukovodstvo dlya vrachei. Moscow: Medical information Agency; 2018].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Araújo Júnior RF de, Garcia VB, Leitão RF de C, Brito GA de C, Miguel E de C, Guedes PMM, et al. Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the AlcoholInduced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells. Avila MA, editor. PLOS ONE. 2016 Feb 18;11(2):e0148868. doi: 10.1371/journal.pone.0148868</mixed-citation><mixed-citation xml:lang="en">Araújo Júnior RF de, Garcia VB, Leitão RF de C, Brito GA de C, Miguel E de C, Guedes PMM, et al. Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the AlcoholInduced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells. Avila MA, editor. PLOS ONE. 2016 Feb 18;11(2):e0148868. doi: 10.1371/journal.pone.0148868</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, et al. Pathology of the liver sinusoids. Histopathology. 2014 Mar 8;64(7):907–20. doi: 10.1111/his.12364</mixed-citation><mixed-citation xml:lang="en">Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, et al. Pathology of the liver sinusoids. Histopathology. 2014 Mar 8;64(7):907–20. doi: 10.1111/his.12364</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Elswefy SE-S, Abdallah FR, Atteia HH, Wahba AS, Hasan RA. Inflammation, oxidative stress and apoptosis cascade implications in bisphenol A-induced liver fibrosis in male rats. International Journal of Experimental Pathology. 2016 Oct;97(5):369–79. doi: 10.1111/iep.12207</mixed-citation><mixed-citation xml:lang="en">Elswefy SE-S, Abdallah FR, Atteia HH, Wahba AS, Hasan RA. Inflammation, oxidative stress and apoptosis cascade implications in bisphenol A-induced liver fibrosis in male rats. International Journal of Experimental Pathology. 2016 Oct;97(5):369–79. doi: 10.1111/iep.12207</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Germani G, Burroughs AK, Dhillon AP. The relationship between liver disease stage and liver fibrosis: a tangled web. Histopathology. 2010 Aug 31;57(6):773–84. doi: 10.1111/j.1365-2559.2010.03609.x</mixed-citation><mixed-citation xml:lang="en">Germani G, Burroughs AK, Dhillon AP. The relationship between liver disease stage and liver fibrosis: a tangled web. Histopathology. 2010 Aug 31;57(6):773–84. doi: 10.1111/j.1365-2559.2010.03609.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kanel GC. Pathology of liver diseases. Chichester, West Sussex: Wiley Blackwell; 2017.</mixed-citation><mixed-citation xml:lang="en">Kanel GC. Pathology of liver diseases. Chichester, West Sussex: Wiley Blackwell; 2017.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mourelle M, Favari L, Amezcua JL. Protection against thallium hepatotoxicity by Silymarin. Journal of Applied Toxicology. 1988 Oct;8(5):351–4. doi: 10.1002/jat.2550080503</mixed-citation><mixed-citation xml:lang="en">Mourelle M, Favari L, Amezcua JL. Protection against thallium hepatotoxicity by Silymarin. Journal of Applied Toxicology. 1988 Oct;8(5):351–4. doi: 10.1002/jat.2550080503</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rasineni K, Penrice DD, Natarajan SK, McNiven MA, McVicker BL, Kharbanda KK, et al. Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. BMC Gastroenterology. 2016 Feb 29;16(1). doi:10.1186/s12876-016-0433-4</mixed-citation><mixed-citation xml:lang="en">Rasineni K, Penrice DD, Natarajan SK, McNiven MA, McVicker BL, Kharbanda KK, et al. Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. BMC Gastroenterology. 2016 Feb 29;16(1). doi:10.1186/s12876-016-0433-4</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Huang Q-H, Li Y-X, Huang Y-F, Xie J-H, Xu L-Q, et al. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Molecular Medicine Reports. 2017 Nov 3;17(1):789–800. doi: 10.3892/mmr.2017.7958</mixed-citation><mixed-citation xml:lang="en">Wang L, Huang Q-H, Li Y-X, Huang Y-F, Xie J-H, Xu L-Q, et al. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Molecular Medicine Reports. 2017 Nov 3;17(1):789–800. doi: 10.3892/mmr.2017.7958</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao S-Y, Oshima K. Liver pathology. New York Demos Medical; 2015.</mixed-citation><mixed-citation xml:lang="en">Xiao S-Y, Oshima K. Liver pathology. New York Demos Medical; 2015.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Luo J, Hu X, Yang F, Zhong S, Lin W. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World Journal of Gastroenterology. 2016;22(8):2558–65. doi: 10.3748/wjg.v22.i8.2558</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Luo J, Hu X, Yang F, Zhong S, Lin W. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World Journal of Gastroenterology. 2016;22(8):2558–65. doi: 10.3748/wjg.v22.i8.2558</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
